Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids.

[1]  D. Giugliano,et al.  Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes mellitus. A new job for an old drug? , 1990, Annals of internal medicine.

[2]  F. Arnett.  Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.

[3]  J. R. Loudon.  Hydroxychloroquine and postoperative thromboembolism after total hip replacement. , 1988, The American journal of medicine.

[4]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[5]  D. Wallace,et al.  Does hydroxychloroquine sulfate prevent clot formation in systemic lupus erythematosus? , 1987, Arthritis and rheumatism.

[6]  H. Lithell,et al.  Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. II. Effects of anti-inflammatory and disease-modifying drug treatment. , 1987, Archives of internal medicine.

[7]  H. Lithell,et al.  Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. I. Relativity to inflammatory activity. , 1987, Archives of internal medicine.

[8]  C. Drevon,et al.  Inhibition of very-low-density lipoprotein secretion by chloroquine, verapamil and monensin takes place in the Golgi complex. , 1987, Biochimica et biophysica acta.

[9]  A. Goldberg,et al.  Dyslipoproteinemia in systemic lupus erythematosus. Effect of corticosteroids. , 1987, The American journal of medicine.

[10]  W. Ettinger,et al.  Effect of short-term, low-dose corticosteroids on plasma lipoprotein lipids. , 1987, Atherosclerosis.

[11]  R. Johnson,et al.  Hydroxychloroquine Sulfate Prophylaxis for Pulmonary Embolism for Patients with Low‐friction Arthroplasty , 1986, Clinical orthopaedics and related research.

[12]  R L Blum,et al.  Computer-assisted design of studies using routine clinical data. Analyzing the association of prednisone and cholesterol. , 1986, Annals of internal medicine.

[13]  Beynen Ac.  Could chloroquine be of value in the treatment of hypercholesterolemia , 1986 .

[14]  Y. Scharf,et al.  Hypocholesterolaemia and abnormal high-density lipoprotein in rheumatoid arthritis. , 1985, British journal of rheumatology.

[15]  H. W. Chen,et al.  Chloroquine inhibits cyclization of squalene oxide to lanosterol in mammalian cells. , 1984, The Journal of biological chemistry.

[16]  S. Eisenberg,et al.  The effects of prednisone therapy on plasma lipoproteins and apolipoproteins: a prospective study. , 1984, Metabolism: clinical and experimental.

[17]  N. LaRusso,et al.  Effect of chloroquine on the form and function of hepatocyte lysosomes. Morphologic modifications and physiologic alterations related to the biliary excretion of lipids and proteins. , 1983, Gastroenterology.

[18]  G. Emerole,et al.  Changes in some rat hepatic microsomal components induced by prolonged administration of chloroquine. , 1983, Biochemical pharmacology.

[19]  C. Bell.  Hydroxychloroquine sulfate in rheumatoid arthritis: long-term response rate and predictive parameters. , 1983, The American journal of medicine.

[20]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[21]  H. Johnsson,et al.  Clinical and experimental evaluation of the thromboprophylactic effect of hydroxychloroquine sulfate after total hip replacement. , 1981, Haemostasis.

[22]  V. Wright,et al.  Some rheological properties of blood during anti-rheumatoid therapy. , 1981, Pharmatherapeutica.

[23]  Y. Matsuzawa,et al.  Studies on drug-induced lipidosis: subcellular localization of phospholipid and cholesterol in the liver of rats treated with chloroquine or 4,4'-bis (diethylaminoethoxy)alpha, beta-diethyldiphenylethane. , 1980, Journal of lipid research.

[24]  J. Charnley,et al.  Hydroxychloroquine in prophylaxis of pulmonary embolism following hip arthroplasty. , 1979, Clinical orthopaedics and related research.

[25]  A. Kandutsch,et al.  Biological activity of some oxygenated sterols. , 1978, Science.

[26]  Wu Tk,et al.  Prophylaxis of deep venous thrombosis by hydroxychloroquine sulfate and heparin. , 1977 .

[27]  M. E. Ainsworth,et al.  Failure of orally administered hydroxychloroquine sulphate to prevent venous thromboembolism following elective hip operations. , 1977, The Journal of bone and joint surgery. American volume.

[28]  O. Chrisman,et al.  Prevention of venous thromboembolism by administration of hydroxychloroquine. A preliminary report. , 1976, The Journal of bone and joint surgery. American volume.

[29]  M. Urowitz,et al.  The bimodal mortality pattern of systemic lupus erythematosus. , 1976, The American journal of medicine.

[30]  M. Brown,et al.  Inhibition of proteolytic degradation of low density lipoprotein in human fibroblasts by chloroquine, concanavalin A, and Triton WR 1339. , 1975, The Journal of biological chemistry.

[31]  J. Mustard.  Platelets, Drugs and Thrombosis , 1975 .

[32]  R. Eban,et al.  Prevention of Postoperative Deep Venous Thrombosis in Legs by Orally administered Hydroxychloroquine Sulphate , 1974, British medical journal.

[33]  Singh Hk,et al.  Prevention of post-operative deep venous thrombosis and pulmonary embolism. , 1973 .

[34]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[35]  R. Perrett,et al.  Prevention of Postoperative Deep Venous Thrombosis and Pulmonary Embolism , 1971, British medical journal.

[36]  Dollery Ct,et al.  Platelets and thrombosis. , 1964, Scottish medical journal.

[37]  B. Madow.  Use of antimalarial drugs as "desludging" agents in vascular disease processes. , 1960, Journal of the American Medical Association.

[38]  D. Adlersberg,et al.  Adrenal Cortex and Lipid Metabolism , 1950, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.